Clinical outcome in a 33-year-old man with Stevens-Johnson syndrome (case 1, right eye). A, Slitlamp photographs of the preoperative condition. The inset shows the left eye of the same patient. Both eyes showed severe conjunctivalization with vascularization. B, One year after autologous cultivated oral mucosal epithelial transplantation, the ocular surface has stabilized and shows decreased vascularization and fibrosis on the cornea. C, Fluorescein staining test results indicate a stable epithelium. The bars conceal information that identifies the patient.
Representative findings of impression cytology. A, Normal oral mucosa. B, Normal conjunctival epithelium. C, Cultivated oral mucosal epithelial sheet (periodic acid–Schiff–hematoxylin, original magnification ×200).
Cytologic evaluation of epithelium at the transplantation site in case 1. A, Before surgery, the epithelium showed a total loss of goblet cells with mild keratinization. B, Peripheral region of the transplantation site 4.5 months after surgery shows a mixture of oral mucosal epithelium (*) and conjunctival epithelium with goblet cells (arrows). C, Center of the transplantation site at 8 months after surgery shows only the cytologic features of oral mucosal epithelium. D and E, Center of the transplantation site 12 months after surgery shows cytologic features of oral mucosal epithelium (D) and conjunctival epithelium with abundant goblet cells (E) (periodic acid-Schiff–hematoxylin, original magnification ×200).
Horseradish peroxidase permeability assay.
Satake Y, Dogru M, Yamane G, Kinoshita S, Tsubota K, Shimazaki J. Barrier Function and Cytologic Features of the Ocular Surface Epithelium After Autologous Cultivated Oral Mucosal Epithelial Transplantation. Arch Ophthalmol. 2008;126(1):23-28. doi:10.1001/archopht.126.1.23
Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008
To determine the barrier function and cytologic features of ocular surface epithelium after autologous cultivated oral mucosal epithelial transplantation in a prospective observational study.
The status of the epithelium in 4 eyes with limbal stem cell deficiency was studied preoperatively and postoperatively. We used an impression method to determine the cytologic features and anterior fluorophotometry to determine barrier function.
Impression cytology showed nonkeratinized, squamous, polygonal, cohesive cells with a low nuclear to cytoplasmic cell ratio and no goblet cells, corresponding to cultivated oral mucosal epithelium, at up to 16 months after surgery. In some cases, the epithelium displayed a mixture of oral mucosal and conjunctival epithelium, especially in cases with a longer postoperative period. Central epithelial permeability remained persistently high throughout the follow-up period, regardless of the epithelial phenotype.
Cultivated oral mucosal epithelial cells were observed to survive for more than 1 year after transplantation, with gradual replacement by conjunctival epithelium in some cases. Decreased barrier function of the transplanted epithelium may have prognostic implications, suggesting the presence of oral mucosal epithelium long after surgery.
When corneal epithelium stem cells1,2 are severely damaged by inflammation or trauma, conjunctival epithelium invades the corneal surface where epithelial defects persist, resulting in limbal stem cell deficiency (LSCD).3- 5 With unilateral LSCD, autologous transplantation of limbal tissues obtained from the healthy fellow eye can be used.6- 9 Bilateral involvement, however, necessitates harvesting of allogenic grafts. Encouraging clinical outcomes have been reported after allogenic transplantation of limbal stem cells.10- 13 However, long-term postoperative immunosuppression is necessary with this approach to prevent allograft rejection. Use of immunosuppressants incurs a high risk of infection, increased intraocular pressure, or systemic adverse effects, resulting in disappointing long-term outcomes.11,14 Recently, the clinical effectiveness of a new method of ocular surface reconstruction, autologous cultivated oral mucosal epithelial transplantation (COMET), has been reported in the treatment of patients with bilateral LSCD.15- 18 The major advantage of this new approach is that it negates the need for postoperative immunosuppressive therapy. Although short-term outcomes are encouraging, long-term outcomes remain uncertain. One factor influencing long-term results is the survival of transplanted epithelial cells, which has not been reported. We studied the progress of transplanted oral mucosal epithelium by performing periodic impression cytology after COMET.
The critically important functions of corneal epithelium are its formation of a smooth refractive surface and its role as a barrier against environmental insults. After COMET, we often observed persistent and increased fluorescein staining at the transplantation site, as described previously.18 This suggested that barrier function was compromised after COMET. Therefore, we also examined barrier function by using a slitlamp fluorophotometer and compared the relationship between cytologic and barrier function results for the first time, to our knowledge, in this study.
We performed COMET in 24 eyes with total LSCD from February 4, 2004, through September 25, 2006, at the Department of Ophthalmology, Tokyo Dental College. Of these, 4 eyes that showed no epithelial defects on the corneal surface underwent cytologic examination and determination of epithelial permeability. Patients included 1 man and 3 women, with a mean age of 52 years. Original diseases included Stevens-Johnson syndrome in 2 eyes and pseudo-ocular cicatricial pemphigoid in 2. Preoperative patient demographic profiles are shown in Table 1. The diagnosis of total LSCD was based on the clinical observation of absence of limbal palisades of Vogt and the presence of goblet cells or keratinized conjunctival cells in the central cornea according to impression cytology findings. The superficial layer of the corneal surface in all cases showed marked squamous metaplasia of stage 3 or higher, according to the 1985 classification by Tseng.19 Informed consent was obtained from all patients. The study was approved by the ethical review board of our institution and conformed to the tenets of the Declaration of Helsinki. None of the patients had a history of systemic or other ocular disease, drug use, or ocular surgery that would aggravate ocular surface status. We performed COMET in all 4 eyes as the first surgery, except in the patient in case 4 (Table 1), who had undergone cultivated autologous corneal limbal epithelium transplantation and had developed a persistent epithelial defect of the cornea. The extent of corneal neovascularization was graded as 0, for no invasion of the cornea; 1, peripheral invasion; 2, midperipheral invasion; and 3, invasion of the entire cornea and extension to the papillary area.
All patients received guidance on oral hygiene and treatment of tooth decay before biopsy. After sterilizing the oral cavity, inferior buccal mucosa was excised using an 8-mm punch biopsy tool (KAI Industries Co, Ltd, Gifu, Japan) while the patient was under local anesthesia. We dissected the specimens and used scissors to remove submucosal connective tissues. The mucosal epithelium was cut into small pieces, and then washed several times to remove blood and adipose tissue in sterile phosphate-buffered saline solution free of calcium and magnesium ions. Specimens were then submerged in a mixture of Dulbecco Modified Eagle Medium and Ham F12 at a ratio of 1:1 (vol/vol) (Invitrogen Corporation, Grand Island, New York) with 10% fetal bovine serum, 5-μg/mL gentamicin (Invitrogen Corporation), and 0.25-μg/mL amphotericin B (Sigma-Aldrich Corp, St Louis, Missouri). The basal cells of the oral mucosal epithelial cells were harvested after enzymatic treatment with 0.8 IU of a grade II neutral protease (Dispase II; Roche Diagnostics, Indianapolis, Indiana) at 4°C for 5 hours, and a solution of 0.05% trypsin and 0.53mM EDTA (Invitrogen Corporation) at room temperature for 10 minutes. The cell suspension was washed and filtered through nylon mesh (BD Biosciences, Bedford, Massachusetts) to remove debris and small pieces of residual material in the Dulbecco Modified Eagle Medium–Ham F12 medium (1:1 mixture) with 10% fetal bovine serum. A single-cell suspension of basal cells from oral mucosal epithelium was resuspended in conditioned medium for oral mucosal epithelium (ArBlast Co, Ltd, Kobe, Japan). The suspension was then seeded (range, 1.0 × 105 cells/well to approximately 2.0 × 105 cells/well) onto human denuded amniotic membrane on the bottom of the culture plate inserts in a 6-well plate (Corning Inc, Corning, New York) containing mitomycin (mitomycin C) (Sigma-Aldrich Corp) treated with 3T3 fibroblasts (2.0 × 104 cells/cm2). The culture was submerged in medium for 2 weeks and exposed to air by lowering the level of the medium at the end of the culture period.15
All abnormal fibrotic tissues invading the corneal surface were removed. Any existing symblepharon was also dissected. After 0.04% mitomycin treatment for 3 minutes followed by thorough washing with sterile isotonic sodium chloride solution, the cultivated oral mucosal epithelial sheets were grafted onto the cornea and sutured at the conjunctival edge with interrupted 8-0 polyglactin 910 sutures (Vicryl; Ethicon Inc, Somerville, New Jersey). At the end of the surgical procedure, a therapeutic contact lens was inserted to protect the ocular surface.
Preservative-free 0.1% betamethasone (Rinbeta PF; Nitten, Nagoya, Japan) and levofloxacin (Cravit; Santen Pharmaceutical Co, Osaka, Japan) were instilled 5 times a day postoperatively, and the doses were tapered over several months. Preservative-free artificial tears, 0.1% or 0.3% preservative-free hyaluronate sodium (Hyalein-Mini; Santen Pharmaceutical Co), and autologous serum eyedrops were used for epithelial management. All patients received systemic betamethasone (Rinderon; Shionogi, Osaka, Japan), 2 mg/d, to reduce postoperative inflammation; the dose was then tapered over the next 2 weeks. No local or systemic immunosuppressants were prescribed during follow-up.
Impression cytology was performed after administration of topical anesthesia with 0.4% benoxinate hydrochloride (oxybuprocaine). Strips of cellulose acetate filter paper (Millipore Corp, Bedford, Massachusetts) were placed on the central cornea and/or the periphery of the transplanted epithelial sheet with a glass rod. The specimens were then fixed with 10% formaldehyde. Specimens were stained with periodic acid–Schiff–hematoxylin reagent (Muto Pure Chemicals Co, Ltd, Tokyo, Japan) that had been dehydrated in ascending grades of ethanol and then xylol, with coverslips added at the final stage. The presence of conjunctival goblet cells and the epithelial cell phenotype were determined under a light microscope at a magnification of ×200. The same researcher (M.D.), masked to clinical information, examined the specimens for the presence of goblet cells, keratinization of epithelium, and mucin pickup.19 Impression cytology was also performed on the inferior buccal mucosa from a healthy volunteer and on unused cultivated mucosal epithelial sheets.
Fluorescein permeability was measured to determine the barrier function of the transplanted epithelium by using a slitlamp fluorophotometer (Anterior Fluorophotometer FL-500; Kowa Co Ltd, Tokyo) as described previously.20 This procedure was performed before surgery, and again during the 1- to 3-month, 6- to 9-month, and 12- to 16-month follow-up periods after surgery. First, intensity of background fluorescence (autofluorescence) was measured 10 times at the central area (0.3 × 0.5 mm) of the grafted cornea, and the average was calculated. We applied 3 μL of 0.5% fluorescein in sterile isotonic sodium chloride solution (5 mg/mL) to the lower conjunctival sac, making sure that no physical contact occurred during the procedure. Ten minutes later, the ocular surface, including the lower tarsal conjunctiva, conjunctival sac, cornea, bulbar conjunctiva, and upper tarsal conjunctiva, were washed with 20 mL of sterile saline solution. After another 20 minutes, intensity of fluorescence at the same central area was measured, and the average intensity was calculated. The mean background value was subtracted from this mean value. The counts obtained were converted into fluorescein concentrations using calibration lines (range, 0-5000 ng/mL) incorporated into the software.
Cultivated oral mucosal epithelial sheets were rinsed with phosphate-buffered saline solution, and then incubated in phosphate-buffered saline solution with 100-mg/mL horseradish peroxidase (HRP) (Wako Pure Chemical Industries, Ltd, Osaka, Japan) for 45 minutes at room temperature. After rinsing twice again with phosphate-buffered saline solution, the epithelial sheets were fixed in 2.5% glutaraldehyde solution (Tabb Laboratory Equipment Ltd, Berkshire, England) overnight. After fixation, the epithelial sheets were rinsed and visualized with 3,3′-diaminobenzidine tetrahydrochloride (Vector Laboratories, Burlingame, California) as a substrate for 10 minutes. Finally, they were rinsed with deionized water, and paraffin sections were prepared for histochemical analysis.
Before surgery, all 4 patients had chronic bilateral total LSCD, accompanied by highly vascularized conjunctival tissue on the cornea, stromal opacity, or symblepharon (Table 1 and Figure 1A). After COMET, all 4 patients showed a stable ocular surface, with no epithelial defects, decreased neovascularization and fibrotic tissues on the cornea, and no symblepharon (Table 2 and Figure 1B and C). No complications such as persistent epithelial defects, recurrence of symblepharon, or infection were observed, except in the patient in case 1, in whom increased intraocular pressure was successfully managed by antiglaucoma medication. No adverse effects of postoperative medication were recognized during follow-up. Postoperative visual acuities did not improve dramatically after COMET because of residual stromal opacity. Patients 1 and 3 underwent keratoplasty at 19 and 6 months, respectively, after COMET, resulting in marked improvement in visual acuity (20/40 and 20/30, respectively). No epithelial problem or immunological rejection was observed.
Cytologic evaluation of the superficial oral mucosal layer showed nonkeratinized squamous, polygonal, cohesive cells with a low nuclear to cytoplasmic cell ratio, and no goblet or inflammatory cells. Mucosal epithelial cells were larger than those of the conjunctival epithelium (Figure 2A). The normal conjunctival epithelial cells were small, round, and compact, with scanty, eosinophilic-staining cytoplasm, and their large nuclei yielded a nuclear to cytoplasmic cell ratio of 1:1 to approximately 1:2. Goblet cells were abundant (Figure 2B). The superficial layer of the cultivated oral mucosal epithelial sheet showed larger nuclei, resulting in a decrease in the nuclear to cytoplasmic cell ratio compared with normal conjunctival epithelium (Figure 2C).
Representative results of impression cytology on peripheral transplanted tissue showed oral mucosal epithelium and conjunctival epithelium in the same area (Figure 3B). Oral mucosal epithelium transplanted onto the ocular surface shared the same characteristics as the cultivated oral mucosal epithelial sheet. The conjunctival epithelium at the transplantation site was also similar in appearance to normal conjunctival epithelium. These cells were small, round, and compact in the presence of goblet cells (Figure 2B and C and Figure 3B).
Longitudinal changes in the cytologic features of case 1 are shown in Figure 3. Before surgery, the corneal surface was covered with conjunctival epithelium showing severe squamous metaplasia, reduced cohesiveness, and no goblet cells (Figure 3A). Cytologic analysis after COMET showed features similar to those of the cultivated oral mucosal epithelial sheet. Only oral mucosal epithelium was observed on the central cornea when examined 4.5 months after transplantation (data not shown). Oral mucosal epithelium was observed on the central area at least 12 months after transplantation in 2 of 3 eyes. In case 4, this observation lasted for up to 16 months after surgery (Table 3). Although conjunctival epithelium with goblet cells was detected at the peripheral grafted area 4.5 months after transplantation (Figure 3B), it tended to gradually invade toward the center of the cornea (Figure 3B and E). The conjunctival epithelium in the other 3 cases showed a time course similar to that of case 1 (Table 3). On impression cytology, none of the specimens exhibited inflammatory cells.
Preoperative values for permeability to fluorescein were high in each case, ranging from 700 to 2700 ng/mL. Postoperative values were persistently higher (Table 4). No correlation was seen between permeability to fluorescein and the results of cytologic analysis (Tables 3 and 4). We also assessed the permeability of the cultivated oral mucosal epithelial sheet to HRP, which has a larger molecule size (40 kDa) than does fluorescein dye (344 Da). Horseradish peroxidase proteins were detected at the apical surface of the superficial layer of the epithelial sheet but not inside the epithelial layer (Figure 4).
Autologous cultivated oral mucosal epithelial transplantation has been reported as a new and useful reconstruction procedure for the ocular surface.16,18 To maintain a stable ocular surface after surgery, it is important to know how long the transplanted epithelium will survive. In this study, we confirmed the presence of transplanted oral mucosal epithelium on the cornea after COMET. Furthermore, the transplanted cells were observed more than 1 year after surgery. We used impression cytology to assess the cytologic features of the normal oral mucosa, cultivated oral mucosal epithelium, and transplanted epithelium. These samples shared mutual cytologic features, including nonkeratinized, squamous, polygonal, cohesive cells with a low nuclear to cytoplasmic cell ratio and no goblet cells, as described by Aguilar et al.21 Because of these cytologic characteristics, it was not difficult to differentiate transplanted oral mucosal epithelium from conjunctival epithelium.
A fundamental function of epithelium is to act as a barrier between the external environment and ocular tissue. We used anterior fluorophotometry to determine barrier function to fluorescein dye in the corneas after COMET. Permeability after COMET was very high (range, 2300 to >5000 ng/mL) during the follow-up period compared with that of conjunctival epithelium (700 to approximately 1400 ng/mL) or that of eyes with severe punctate corneal staining (Table 4).20 The values were persistently high, despite longitudinal changes in cytologic features.
In general, the barrier function of the epithelium reflects the structural integrity of the tissue. Oral mucosa does not have uniform thickness but shows regional variation and consists of keratinized and nonkeratinized squamous epithelium.22 Nonkeratinized epithelium in the oral cavity is a highly permeable tissue, and its barrier function depends on its thickness. Areas of single-layer epithelium in the oral cavity, such as the sublingual area, are capable of absorbing drugs.22 In this study, oral mucosal tissue was harvested from a nonkeratinized region, and only 4 to 6 layers of the epithelium were reconstructed on the amniotic membrane (data not shown). It is possible that the barrier function of cultivated oral mucosal sheets cannot be maintained at this thickness. Highly permeable transplanted epithelium may, therefore, suggest the presence of oral mucosal epithelium.
Low barrier function may indicate susceptibility to infection. However, infection after COMET was outside the scope of this study.23 We found that HRP, which has a molecular weight of 40 kDa, did not penetrate the superficial layer of the cultivated oral mucosal epithelium (Figure 4). This suggests that cultivated oral mucosal epithelium has sufficient barrier function to prevent invasion by pathological organisms. Avoidance of long-term use of immunosuppressants may be a more important factor in reducing the risk of postoperative infection. Nonetheless, decreased barrier function after COMET may influence the penetration rates of small molecules such as those contained in eyedrops.
Segmental ingrowth of conjunctival epithelium with goblet cells was observed in some cases (Figure 3B). The regenerating conjunctival epithelium showed decreased squamous metaplasia and increased goblet cell density compared with the preoperative findings (Figure 3A and E). Because this regenerating conjunctiva was associated with low fibrosis and vascularization, the ocular surface remained stable with some transparency. The cytologic improvement of the conjunctival epithelium seen in our study may have been due to reduced inflammation or presence of a suitable substrate amniotic membrane, as previously reported.24 In addition, possible mucin expression changes after COMET may contribute to the improvement of the ocular surface status.
There were some limitations in the present study arising from factors such as variation in the original disease, tear function, lid abnormality, trichiasis, and meibomian gland function. This variation may have influenced the survival and phenotypic changes in the transplanted epithelium after COMET. In addition, the follow-up periods were relatively short: 2 eyes underwent corneal transplantation for visual recovery at 16 and 9 months after COMET (Table 1). Therefore, further studies with a larger number of cases and a longer follow-up period are necessary to clarify these factors.
In conclusion, impression cytology findings confirmed that transplanted oral mucosal epithelium survived longer than 1 year after COMET. Although increased permeability to fluorescein dye was demonstrated by anterior fluorophotometry, the transplanted epithelium appeared to retain barrier function against large molecules.
Correspondence: Yoshiyuki Satake, MD, PhD, Department of Ophthalmology, Tokyo Dental College, Sugano 5-11-13, Ichikawa, Chiba, 272-8513, Japan (email@example.com).
Submitted for Publication: May 2, 2007; final revision received June 13, 2007; accepted June 14, 2007.
Financial Disclosure: None reported.
Funding/Support: This study was supported by Grant-in-Aid for Young Scientists (B) KAKENHI 17791259 from the Japan Society for the Promotion of Science and by a grant from the Advanced and Innovational Research Program in Life Sciences of the Ministry of Education, Culture, Sports, Science and Technology.
Additional Contributions: Morio Tonogi, DDS, Kazunari Higa, PhD, and Fumito Morito provided the oral mucosal tissue samples and cultivation of the oral mucosal epithelium in this study. Jeremy Williams, of Tokyo Dental College, provided advice on the English language for the manuscript.